King简明间质性肺病问卷在进展性纤维化ILD中的心理测量学特性及治疗反应阈值
本研究基于INBUILD试验中663例非IPF的进展性纤维化ILD患者,验证King简明间质性肺病问卷(K-BILD)测量健康相关生活质量的性能,并估算有意义的改变阈值。结果显示K-BILD内部一致性良好,重测信度ICC为0.74,与FVC%预计值相关性弱,可区分不同疾病严重程度组,总评分≥-2单位可定义稳定/改善与进展性恶化。
要点
- K-BILD在进展性纤维化ILD中内部一致性良好,总评分Cronbach's α为0.94。
- K-BILD总评分重测信度ICC为0.74,与FVC%预计值相关性弱。
- K-BILD总评分≥-2单位可区分稳定/改善与进展性恶化。
核心结论
- K-BILD是评估进展性纤维化ILD患者健康相关生活质量的有效工具。
- K-BILD总评分≥-2单位可作为定义治疗反应(稳定/改善 vs 进展性恶化)的有意义改变阈值。
研究设计与样本
- 基于INBUILD试验数据的事后分析,纳入663例非IPF的进展性纤维化ILD患者。
- 评估K-BILD的内部一致性、重测信度、结构效度、已知组效度和反应度,并采用锚定法和分布法计算有意义改变阈值。
主要发现
- K-BILD总评分Cronbach's α为0.94,呼吸困难与活动维度0.88,心理维度0.91,胸部症状维度0.79。
- K-BILD总评分重测信度ICC为0.74。
- K-BILD与FVC%预计值呈弱相关。
- 基于是否需要补充氧气或基线FVC%预计值(≤70%或>70%)划分的疾病严重程度组间,K-BILD评分差异显著。
- 估算K-BILD总评分有意义改变阈值为≥-2单位,用于定义稳定/改善与进展性恶化。
关键数值与推荐
- K-BILD总评分内部一致性Cronbach's α为0.94。
- K-BILD总评分重测信度ICC为0.74。
- K-BILD总评分有意义改变阈值为≥-2单位。
临床怎么用
- 临床可将K-BILD用于进展性纤维化ILD患者健康相关生活质量的评估。
- 以K-BILD总评分变化≥-2单位作为判断治疗反应(稳定/改善)的参考阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a lack of fully validated patient-reported outcome measures for progressive fibrosing interstitial lung disease (ILD). We aimed to validate the King's Brief Interstitial Lung Disease (K-BILD) questionnaire for measuring health-related quality of life (HRQoL) in these patients. We also aimed to estimate the meaningful change threshold for interpreting stabilisation of HRQoL as a clinical end-point in progressive fibrosing ILD, where the current goal of treatment is disease stability and slowing progression. METHODS: This analysis evaluated data from 663 patients with progressive fibrosing ILD other than idiopathic pulmonary fibrosis from the INBUILD trial. Validation of the measurement properties was assessed for internal consistency, test-retest reliability, construct validity, known-groups validity and responsiveness. We calculated meaningful change thresholds for treatment response using anchor-based (within-patient) and distribution-based methods. RESULTS: K-BILD had strong internal consistency (Cronbach's α was 0.94 for total score, 0.88 for breathlessness and activities, 0.91 for psychological, and 0.79 for chest symptoms). The test-retest reliability intraclass correlation coefficient was 0.74 for K-BILD total score. K-BILD demonstrated weak correlations with forced vital capacity (FVC) percent predicted. Known-groups validity showed significant differences in K-BILD scores for patient groups with different disease severity based on use of supplemental oxygen or baseline FVC % pred (≤70% or >70%). We estimated a meaningful change threshold of ≥ -2 units for K-BILD total score for defining patients who remain stable/improved versus those with progressive deterioration. CONCLUSIONS: Our results validate K-BILD as a tool for assessing HRQoL in patients with progressive fibrosing ILD and set a meaningful change threshold of ≥ -2 units for K-BILD total score.
引用
- Birring SS, Bushnell DM, Baldwin M, et al. The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases. Eur Respir J. 2022. PMID: 34764181. doi:10.1183/13993003.01790-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。